Core Insights - Lifevantage (LFVN) reported quarterly earnings of $0.18 per share, exceeding the Zacks Consensus Estimate of $0.17 per share, and showing an increase from $0.15 per share a year ago, resulting in an earnings surprise of +5.88% [1][2] - The company posted revenues of $47.56 million for the quarter ended September 2025, which fell short of the Zacks Consensus Estimate by 10.92%, and represents a slight increase from $47.21 million year-over-year [2] - Lifevantage shares have declined approximately 58.1% year-to-date, contrasting with the S&P 500's gain of 16.5% [3] Earnings Outlook - The future performance of Lifevantage's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4][6] - The current consensus EPS estimate for the upcoming quarter is $0.22 on revenues of $57.83 million, and for the current fiscal year, it is $1.05 on revenues of $232.54 million [7] Industry Context - Lifevantage operates within the Zacks Medical - Dental Supplies industry, which is currently ranked in the top 23% of over 250 Zacks industries, indicating a favorable industry outlook [8] - The performance of Lifevantage's stock may also be influenced by the overall industry trends and the earnings estimate revisions, which have shown a mixed trend ahead of the earnings release [5][6]